Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project

Abstract Introduction Multiple sclerosis (MS) is a chronic neurodegenerative disease that leads to impaired cognitive function and accumulation of disability, with significant socioeconomic burden. Serious unmet need in the context of managing MS has given rise to ongoing research efforts, leading t...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Damiano Paolicelli, Giovanna Borriello, Raffaella Clerici, Elena Colombo, Davide Croce, Emanuele D’Amico, Nicola De Rossi, Alessia Di Sapio, Giuseppe Fenu, Davide Maimone, Girolama A. Marfia, Marcello Moccia, Paola Perini, Maria G. Piscaglia, Lorenzo Razzolini, Massimo Riccaboni, Elisabetta Signoriello, Gianluca Agostoni, Alberto Farina, Margaret Mondino, Francesco Berruto, Alessia Tettamanti, Francesca Donnaloja, Carla Tortorella
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Adis, Springer Healthcare 2024-08-01
Sarja:	Neurology and Therapy
Aiheet:	Multiple sclerosis Costs Forecast Italian National Healthcare Service expenditure BTKi Treatment pattern
Linkit:	https://doi.org/10.1007/s40120-024-00644-3
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!